Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 6—June 2011

Outcome Predictors in Treatment of Yaws

Oriol MitjàComments to Author , Russell Hays, Anthony Ipai, David Gubaila, Francis Lelngei, Martin Kirara, Raymond Paru, and Quique Bassat
Author affiliations: Author affiliations: Lihir Medical Centre, Lihir Island, Papua New Guinea (O. Mitjà, R. Hays, A. Ipai, D. Gubaila, F. Lelngei, M. Kirara, R. Paru); Barcelona Centre for International Health Research, Barcelona, Spain (Q. Bassat)

Main Article

Table 1

Demographic data, clinical signs/symptoms, laboratory results, and outcome after treatment of yaws in 138 case-patients, Papua New Guinea, January–September, 2009*

Characteristic Total no. (%) patients, N = 138
Mean age, y (SD) 9.6 (4.4)
Male sex
81 (58.7)
VDRL titer
16 54 (39.1)
32 33 (23.9)
64 42 (30.4)
9 (6.5)
Primary skin lesion 81 (58.7)
Secondary stage
63 (45.7)†
Family history
36 (26.1)
Treatment with IM penicillin G benzathine 138 (100.0)
Clinical healing 132 (95.7)
Concurrent disease 7 (5.1)‡
Seroconversion 63 (45.7)
Serologically defined treatment failure 24 (17.4)

*VDRL, Venereal Disease Research Laboratory; IM, intramuscular.
†Includes 7 cases of early yaws osteoperiostitis, among whom were 3 patients with dactylilitis.
‡Includes 3 cases of Plasmodium falciparum malaria, 1 case of P. vivax malaria, 1 case of acute diarrhea diagnosed at the 12-month follow-up visit, and 2 case-patients with a chronic underlying disease (1 case of congenital heart disease and 1 case of chronic asthma).

Main Article

Page created: September 01, 2011
Page updated: September 01, 2011
Page reviewed: September 01, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.